Intensive Care and Organ Support Related Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis. (3rd March 2023)

• Record Type: Journal Article
• Authors: Chandel, Abhimanyu; Leazer, Sahar; Alcover, Karl C.; Farley, Josiah; Berk, Joshua; Jayne, Christopher; Mcnutt, Ryan; Olsen, Meredith; Allard, Rhonda; Yang, Jiahong; Johnson, Caitlyn; Tripathi, Ananya; Rechtin, Maria; Leon, Mathew; Williams, Mathias; Sheth, Phorum; Messer, Kyle; Chung, Kevin K.; Collen, Jacob
• Is Part Of: Critical care explorations. Volume 5:Number 3(2023)
• Page Start: e0876
• Publication Date: 2023-03-03
• Subjects: COVID-19 -- mechanical ventilation -- pneumonia -- respiratory distress syndrome -- respiratory insufficiency -- viral
• DOI: 10.1097/CCE.0000000000000876
• Languages: English
• ISSNs: 2639-8028

Abstract

Abstract : OBJECTIVES: To perform a systematic review and meta-analysis to generate estimates of mortality in patients with COVID-19 that required hospitalization, ICU admission, and organ support. DATA SOURCES: A systematic search of PubMed, Embase, and the Cochrane databases was conducted up to December 31, 2021. STUDY SELECTION: Previously peer-reviewed observational studies that reported ICU, mechanical ventilation (MV), renal replacement therapy (RRT) or extracorporeal membrane oxygenation (ECMO)-related mortality among greater than or equal to 100 individual patients. DATA EXTRACTION: Random-effects meta-analysis was used to generate pooled estimates of case fatality rates (CFRs) for in-hospital, ICU, MV, RRT, and ECMO-related mortality. ICU-related mortality was additionally analyzed by the study country of origin. Sensitivity analyses of CFR were assessed based on completeness of follow-up data, by year, and when only studies judged to be of high quality were included. DATA SYNTHESIS: One hundred fifty-seven studies evaluating 948, 309 patients were included. The CFR for in-hospital mortality, ICU mortality, MV, RRT, and ECMO were 25.9% (95% CI: 24.0–27.8%), 37.3% (95% CI: 34.6–40.1%), 51.6% (95% CI: 46.1–57.0%), 66.1% (95% CI: 59.7–72.2%), and 58.0% (95% CI: 46.9–68.9%), respectively. MV (52.7%, 95% CI: 47.5–58.0% vs 31.3%, 95% CI: 16.1–48.9%; p = 0.023) and RRT-related mortality (66.7%, 95% CI: 60.1–73.0% vs 50.3%, 95% CI: 42.4–58.2%; p = 0.003) decreased from 2020 to 2021. CONCLUSIONS: We present updated estimates of CFR for patients hospitalized and requiring intensive care for the management of COVID-19. Although mortality remain high and varies considerably worldwide, we found the CFR in patients supported with MV significantly improved since 2020.